Condition

Pregnancy Complications

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 105 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials105

Recruiting27

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical StudyNCT07669935 · 2026-09-08

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal PatientsNCT07540585 · 2026-07-15

Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic PatientsNCT07554287 · 2026-05-26

Glycemic Markers for Predicting Gestational Diabetes in Pregnant Women With Previous Bariatric SurgeryNCT07517406 · 2026-02-01

Cardiometabolic Disease and Substrate MetabolismNCT07565727 · 2025-12-10

Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 DiabetesNCT07240012 · 2025-12-01

Delivering HOPE (Helping Women Optimize Prenatal Equity)NCT06814509 · 2025-06-24

Sarcopenia in Gestational DiabetesNCT06876090 · 2025-05-28

Autophagy/Apoptosis Balance in Placental Vascular PathologiesNCT06779916 · 2025-05-02

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesNCT06535789 · 2025-05-01

Placental Imaging TechniquesNCT06861309 · 2025-04-23

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsiaNCT06802861 · 2025-01-01

Treatment With Aspirin After Preeclampsia: TAP TrialNCT06281665 · 2024-05-29

Early Versus Late Monitoring Among Pregnant Women With a History of Gestational DiabetesNCT06545227 · 2023-11-20

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)NCT05114096 · 2023-07-20

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionNCT07361679 · 2023-01-18

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody SyndromeNCT05786235 · 2022-12-06

Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant CohortNCT06542718 · 2022-10-03

Better Lifestyle Counseling for African American Women During PregnancyNCT05234125 · 2022-08-16

Oral Health and Adverse Pregnancy ComplicationsNCT06110143 · 2021-11-13

Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in PreconceptionNCT04242069 · 2021-06-18

Human Genes and Microbiota in Early LifeNCT06926166 · 2019-04-01

Shenzhen Birth Cohort StudyNCT03830879 · 2018-03-06

Berlin-Brandenburg Pregnancy CohortNCT03313024 · 2017-09-26

Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy OutcomesNCT05753124 · 2015-05-01

Biobank on Prematurity, Preeclampsia and Other Pregnancy ComplicationsNCT02744365 · 2015-04-01

The Jiaxing Birth Cohort in ChinaNCT03217656 · 1999-01-01

Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia PreventionNCT07614893 · 2027-05-01

NOT_YET_RECRUITING

Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) DisparitiesNCT06915428 · 2026-10-01

NOT_YET_RECRUITING

Effect of Body Mass Index on ICSI OutcomesNCT07832825 · 2026-09-20

NOT_YET_RECRUITING

Lifestyle Interventions to Improve Glycemic Parameters and Reduce Gestational Diabetes in High-risk Pregnant IndividualsNCT06445270 · 2026-08-01

Climate-Safe Pregnancy Intervention for Women With PreeclclampsiaNCT07564856 · 2025-07-01

Health Belief Model Based Education for Pregnant Women With Gestational DiabetesNCT06740695 · 2025-01-01

NOT_YET_RECRUITING

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOSNCT06545994 · 2024-06-28

Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection FractionNCT06338943 · 2024-03-18

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)NCT06417411 · 2024-03-16

ACTIVE_NOT_RECRUITING

Diamine Oxidase and Adverse Pregnancy OutcomesNCT06281366 · 2024-02-16

Optimal Blood Pressure Treatment Thresholds PostpartumNCT06069102 · 2023-11-15

Educational TOolS for Pregnant Women With Diabetes MellitusNCT06250192 · 2023-09-01

Eliminating Severe Maternal Morbidity With Heart Health Doulas TrialNCT05655936 · 2023-06-29

ACTIVE_NOT_RECRUITING

Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI JakartaNCT06268509 · 2023-04-01

Timing of Ambulation and Infant Birth Weight in Gestational DiabetesNCT06157684 · 2022-10-01

the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)NCT05948319 · 2022-10-01

Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot StudyNCT05527327 · 2022-09-16

The Microbiome in (Non-) Obese Pregnancy and Pregnancy OutcomesNCT05754645 · 2022-07-21

Healthy Eating in Women at Risk of Gestational DiabetesNCT05299502 · 2022-06-30

ACTIVE_NOT_RECRUITING

Oral Prophylactic Measures on the Occurrence of Pre-eclampsia (OP-PE)NCT04989075 · 2022-03-15

Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women With or Without a High Risk for GDMNCT05537480 · 2022-01-14

Gestational Diabetes Monitoring and ManagementNCT06963528 · 2021-12-01

ACTIVE_NOT_RECRUITING

Gasdermin-D and Pannexin-1 in PregnancyNCT05475951 · 2021-12-01

The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese PopulationNCT05089175 · 2021-11-30

Gestational Diabetes Mellitus (GDM) in Pregnant WomenNCT05265741 · 2021-11-09

Measuring sVAP-1 as a Predictor of Pregnancy ProblemsNCT04891315 · 2021-07-25

OneinSeven Gestational Diabetes Genetic and Socioeconomic Risk StudyNCT04789473 · 2021-06-24

Breastfeeding and Postpartum Cardiovascular HealthNCT04580927 · 2021-03-15

The START Clinic: a Feasibility StudyNCT04488861 · 2021-03-15

Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of PregnancyNCT04767438 · 2021-03-01

Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm BirthNCT04494529 · 2021-03-01

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesNCT04769167 · 2021-02-01

Furosemide vs. Placebo for Severe Antepartum HypertensionNCT04615624 · 2021-01-04

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

placebo4 metformin2 aspirin1 furosemide1 remifentanil1 tinzaparin1

Leading sponsors

Harvard School of Public Health (HSPH) 3 CHU de Quebec-Universite Laval 2 Copenhagen University Hospital, Rigshospitalet 2 Duke University 2 Indiana University 2 McGill University Health Centre/Research Institute of the McGill University Health Centre 2 McMaster University 2 Medical University of Vienna 2 Oslo University Hospital 2 Tel-Aviv Sourasky Medical Center 2 University of Pittsburgh 2 University of Tennessee Graduate School of Medicine 2 Alexandra Hospital, Athens, Greece 1 Alisse Hauspurg 1 Assiut University 1

Trial status mix

COMPLETED38

RECRUITING27

UNKNOWN26

ACTIVE_NOT_RECRUITING4

NOT_YET_RECRUITING4

TERMINATED3

SUSPENDED2

WITHDRAWN1

Phase mix

NA38

PHASE39

PHASE45

PHASE23

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.